MaineMOM is a MaineCare model that improvs care for pregnant and postpartum people with opioid use disorder and their infants by integrating perinatal and postpartum care with substance use treatment services. Eighteen (18) sites across Maine deliver MaineMOM Services. Collectively, these sites have provided over 250 MaineMOM members with essential and compassionate care since 2021. The MaineMOM MaineCare rule, adopted in December 2023, guides MaineMOM services and can be found in the MaineCare Benefits Manual, Chapter II, Section 89.
Information about MaineMOM service locations across the state can be found at MaineMOM.org.
MaineMOM Services
MaineCare MaineMOM services will:
- Perinatal care up to twelve months postpartum with integrated OUD treatment
- Care plans development to support individual needs of patients, and identify health-related social needs
- Transition support between inpatient, outpatient, and other care settings
- Referrals for community resources
- Substance use and perinatal care education
- Access to recovery-focused services
MaineMOM Healthcare Partners
The Office of MaineCare Services is collaborating with healthcare sites across Maine to test the delivery of MaineMOM Services beginning July 1, 2021. To find a MaineMOM provider, please go to MaineMOM.org.
MaineMOM is working to expand its network of services to reach more patients across the state of Maine. If you are interested in becoming a MaineMOM Services provider, please visit the MaineMOM Services Provider Application.
-
Clinical Resources and Recommendations
-
Breastfeeding & Substance Use Disorder (SUD)
- Clinical Guidelines for Breastfeeding and Substance Use (ABM, 2015)
- Guide to Support Breastfeeding for People with OUD (NNEPQIN, 2018)
- Marijuana Use in Pregnancy and While Breastfeeding (PDF)
- Research Report on Substance Use while Pregnant and Breastfeeding (NIDA, 2020)
- Breastfeeding and Alcohol, Drugs, and Smoking
Buprenorphine Monotherapy vs. Combination Therapy during Pregnancy
Hepatitis C & SUD
- Hepatitis - Disease Surveillance Epidemiology Program - MECDC; DHHS Maine
- MaineMOM Hepatitis C Treatment Guide (PDF)
- Clinical Recommendations for Hepatitis C Screening in Adults (CDC, 2020)
- Algorithm for Screening and Treating hepatitis C in Pregnant and Postpartum Women (PDF)
- Algorithm for Screening and Treating Hepatitis C in Perinatally Exposed Infants (PDF)
Infant Care
- Overview of the Eat, Sleep, Console Model of Care (NICHQ)
- Approaches to Coordinated Care for Mothers
- Clinical Recommendations for Testing, Managing, and Treating Hepatitis C in Children (AASLD & IDSA, 2020)
MaineMOM Learning Collaboration ECHO Sessions
Mental Health
- Treatment Guidance for SUD and Co-Occurring Disorders: SAMHSA TAP 42 (SAMHSA, 2020)
- Clinical Recommendations on Screening for Perinatal Depression (ACOG, 2018)
- Webinar Addressing Perinatal Mood and Anxiety Disorders (ACOG, 2019)
- FAQ on Postpartum Depression (ACOG, 2019)
- Tools to Support Postpartum Mental Health (Postpartum Support International)
Pain Management
- Recommended Perioperative Management of Patients Prescribed Buprenorphine for OUD: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020)
- Clinical Recommendations for Managing Pain During and After Delivery (MCPAP, 2019)
Poly- and Other Substance Use During Pregnancy
- Polysubstance Use During Pregnancy | Pregnancy | CDC
- Recommended Treatment of Co-Occurring Stimulant Use Disorder and Opioid Use Disorder: Proposed Position of Maine Opioid Response Clinical Advisory Committee (Maine DHHS, 2020)
- Clinical Recommendations on Marijuana Use During Pregnancy and Lactation (SCOG, 2017)
- Research Report on Substance Use While Pregnant and Breastfeeding (NIDA, 2020)
- Fetal Alcohol Spectrum Disorders (FAQ) - (ACOG -- 2024)
Postpartum Reproductive Planning and Contraceptive Care
- Clinical Recommendations on Optimal Postpartum Care (ACOG, 2018)
- Increasing Access to Reproductive Health for People with OUD (Power to Decide, 2018)
Screening for Health-Related Social Needs
Stigma Awareness and SUD
- Online Resource on Stigma of Substance Use in Pregnancy (March of Dimes)
- Substance Use in Pregnancy: Identifying Stigma and Improving Care (PDF)
- Tool to Improve Provider-Patient Conversations about Substance Use (Maine Quality Counts, 2018)
- Words Matter - Terms to Use and Avoid When Talking About Addiction: Self-study module with CME credits from National Institute on Drug Abuse
- Your Words Matter -- Language Showing Compassion and Care for Women, Infants, Families, and Communities Impacted by SUD: Self-study module with CME credits from National Institute on Drug Abuse
Substance Exposed Infants
- Plan of Safe Care | CDC Maternal and Child Health | Population Health | Maine DHHS
- Information Webpage on Neonatal Abstinence Syndrome (March of Dimes, 2019)
- Rack Cards on Substance Exposed Infants (Maine Prevention Store, 2020)
Treatment Recommendations for Opioid Use Disorder during Pregnancy
- Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder (Office of MaineCare Services, 2021) (PDF)
- Clinical Guidance for Treating Pregnant and Parenting Individuals with Opioid Use Disorder and their Infants (SAMHSA, 2018)
- FAQ on Substance Use and Pregnancy (ACOG, 2020)
Urine Toxicology Testing
-
Patient Education Materials and Resources
-
Contraception
Hepatitis C
- Hepatitis C and Pregnancy: A Guide for Hepatitis C, Pregnancy and Babies (maine.gov)
- Hepatitis - Disease Surveillance Epidemiology Program - MeCDC; DHHS Maine
Maine Harm Reduction Services
- Know Your Options (Overdose Prevention Through Intensive Outreach Naloxone and Safety) | Maine DHHS
- Syringe Service Programs
Maine Intimate Partner Violence Resources
- Sexual Assault Crisis & Support Center
- Maine Coalition Against Sexual Assault
- Maine Coalition to End Domestic Violence
Mental Health
- Patient Education on Postpartum Depression and Anxiety (ACNM, 2019)
- Patient Education on Perinatal Depression (NIH, 2020)
- Postpartum Depression | ACOG
Opioid Use Disorder (OUD) During Pregnancy
- Fact Sheets for Treating OUD During Pregnancy (SAMHSA, 2018)
- Poster on Pregnant or Thinking of Having a Baby and OUD (SAMHSA, 2019)
Substance Exposed Infants
- Women, Infants and Families in Maine: Plan of Safe Care
- Patient Brochure on Neonatal Abstinence Syndrome (NNEPQIN, 2018)
- Informational Webpage on Neonatal Abstinence Syndrome (March of Dimes, 2019)
Other Substance Use During Pregnancy
- Substance Use During Pregnancy - Patient Education Webpage (UCSF Health)
- Marijuana Use During Pregnancy and Lactation | ACOG
- Tobacco, Alcohol and Other Drug Use During Pregnancy (Patient FAQ) (ACOG, 2020)
- Tobacco Cessation Support - Maine QuitLink
-
Maine MOM Model Initiative and Grant Award
Maine was awarded $5.3 million cooperative agreement from the Centers for Medicare and Medicaid (CMS) to participate in the Maternal Opioid Misuse (MOM) model. See the CMS MOM Press Release or the Maine DHHS MOM Award Press Release for more information about the award.
The MaineMOM initiative aims to:
- Implement a “No wrong door" approach to screening, welcoming, and engaging women in care
- Design a system of treatment and recovery for mothers, using a medication first model of Medication Assisted Treatment (MAT)
- Increase access to evidenced-based care by integrated perinatal and substance use healthcare teams
- Coordinate care for pregnant women and mothers with substance use disorders within local communities and across the state of Maine
- Conduct a public outreach campaign aimed at increasing awareness of supportive services and reducing stigma for pregnant women and mothers
See the MaineMOM FactSheet (PDF) for a summary of the model.
Questions?
Email the MaineMOM@maine.gov for questions about the initiative, upcoming events, and meetings.
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award with 100 percent funding by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by CMS/HHS, or the U.S. Government.